273 related articles for article (PubMed ID: 18835031)
1. A short Nur77-derived peptide converts Bcl-2 from a protector to a killer.
Kolluri SK; Zhu X; Zhou X; Lin B; Chen Y; Sun K; Tian X; Town J; Cao X; Lin F; Zhai D; Kitada S; Luciano F; O'Donnell E; Cao Y; He F; Lin J; Reed JC; Satterthwait AC; Zhang XK
Cancer Cell; 2008 Oct; 14(4):285-98. PubMed ID: 18835031
[TBL] [Abstract][Full Text] [Related]
2. B cell lymphoma 2 (Bcl-2) residues essential for Bcl-2's apoptosis-inducing interaction with Nur77/Nor-1 orphan steroid receptors.
Banta KL; Wang X; Das P; Winoto A
J Biol Chem; 2018 Mar; 293(13):4724-4734. PubMed ID: 29414782
[TBL] [Abstract][Full Text] [Related]
3. Cotreatment with BCL-2 antagonist sensitizes cutaneous T-cell lymphoma to lethal action of HDAC7-Nur77-based mechanism.
Chen J; Fiskus W; Eaton K; Fernandez P; Wang Y; Rao R; Lee P; Joshi R; Yang Y; Kolhe R; Balusu R; Chappa P; Natarajan K; Jillella A; Atadja P; Bhalla KN
Blood; 2009 Apr; 113(17):4038-48. PubMed ID: 19074726
[TBL] [Abstract][Full Text] [Related]
4. Paclitaxel directly binds to Bcl-2 and functionally mimics activity of Nur77.
Ferlini C; Cicchillitti L; Raspaglio G; Bartollino S; Cimitan S; Bertucci C; Mozzetti S; Gallo D; Persico M; Fattorusso C; Campiani G; Scambia G
Cancer Res; 2009 Sep; 69(17):6906-14. PubMed ID: 19671798
[TBL] [Abstract][Full Text] [Related]
5. Conversion of Bcl-2 from protector to killer by interaction with nuclear orphan receptor Nur77/TR3.
Lin B; Kolluri SK; Lin F; Liu W; Han YH; Cao X; Dawson MI; Reed JC; Zhang XK
Cell; 2004 Feb; 116(4):527-40. PubMed ID: 14980220
[TBL] [Abstract][Full Text] [Related]
6. Cancer-specific toxicity of apoptin is independent of death receptors but involves the loss of mitochondrial membrane potential and the release of mitochondrial cell-death mediators by a Nur77-dependent pathway.
Maddika S; Booy EP; Johar D; Gibson SB; Ghavami S; Los M
J Cell Sci; 2005 Oct; 118(Pt 19):4485-93. PubMed ID: 16179607
[TBL] [Abstract][Full Text] [Related]
7. Peptide screening to knockdown Bcl-2's anti-apoptotic activity: implications in cancer treatment.
Raghav PK; Verma YK; Gangenahalli GU
Int J Biol Macromol; 2012 Apr; 50(3):796-814. PubMed ID: 22155216
[TBL] [Abstract][Full Text] [Related]
8. Nuclear magnetic resonance study of protein-protein interactions involving apoptosis regulator Diva (Boo) and the BH3 domain of proapoptotic Bcl-2 members.
Santiveri CM; Sborgi L; de Alba E
J Mol Recognit; 2012 Dec; 25(12):665-73. PubMed ID: 23192964
[TBL] [Abstract][Full Text] [Related]
9. Optimization of novel oxidative DIMs as Nur77 modulators of the Nur77-Bcl-2 apoptotic pathway.
Tu X; Chen X; Zhang D; Gao M; Liang J; Bao G; Zhang J; Peng S; Zhang X; Zeng Z; Su Y
Eur J Med Chem; 2021 Feb; 211():113020. PubMed ID: 33279290
[TBL] [Abstract][Full Text] [Related]
10. During negative selection, Nur77 family proteins translocate to mitochondria where they associate with Bcl-2 and expose its proapoptotic BH3 domain.
Thompson J; Winoto A
J Exp Med; 2008 May; 205(5):1029-36. PubMed ID: 18443228
[TBL] [Abstract][Full Text] [Related]
11. Effect of HA14-1 on apoptosis-regulating proteins in HeLa cells.
Rehman K; Tariq M; Akash MS; Gillani Z; Qazi MH
Chem Biol Drug Des; 2014 Mar; 83(3):317-23. PubMed ID: 24118733
[TBL] [Abstract][Full Text] [Related]
12. Cell permeable BH3-peptides overcome the cytoprotective effect of Bcl-2 and Bcl-X(L).
Vieira HL; Boya P; Cohen I; El Hamel C; Haouzi D; Druillenec S; Belzacq AS; Brenner C; Roques B; Kroemer G
Oncogene; 2002 Mar; 21(13):1963-77. PubMed ID: 11960369
[TBL] [Abstract][Full Text] [Related]
13. Intracellular delivery of peptide cargos using iron oxide based nanoparticles: studies on antitumor efficacy of a BCL-2 converting peptide, NuBCP-9.
Kumar M; Singh G; Sharma S; Gupta D; Bansal V; Arora V; Bhat M; Srivastava SK; Sapra S; Kharbanda S; Dinda AK; Singh H
Nanoscale; 2014 Nov; 6(23):14473-83. PubMed ID: 25340469
[TBL] [Abstract][Full Text] [Related]
14. Modulation of orphan nuclear receptor Nur77-mediated apoptotic pathway by acetylshikonin and analogues.
Liu J; Zhou W; Li SS; Sun Z; Lin B; Lang YY; He JY; Cao X; Yan T; Wang L; Lu J; Han YH; Cao Y; Zhang XK; Zeng JZ
Cancer Res; 2008 Nov; 68(21):8871-80. PubMed ID: 18974131
[TBL] [Abstract][Full Text] [Related]
15. BH3 mimetics inhibit growth of chondrosarcoma--a novel targeted-therapy for candidate models.
Morii T; Ohtsuka K; Ohnishi H; Mochizuki K; Yoshiyama A; Aoyagi T; Hornicek FJ; Ichimura S
Anticancer Res; 2014 Nov; 34(11):6423-30. PubMed ID: 25368242
[TBL] [Abstract][Full Text] [Related]
16. Involvement of both extrinsic and intrinsic apoptotic pathways in apoptosis induced by genistein in human cervical cancer cells.
Kim SH; Kim SH; Lee SC; Song YS
Ann N Y Acad Sci; 2009 Aug; 1171():196-201. PubMed ID: 19723056
[TBL] [Abstract][Full Text] [Related]
17. Nur77 converts phenotype of Bcl-B, an antiapoptotic protein expressed in plasma cells and myeloma.
Luciano F; Krajewska M; Ortiz-Rubio P; Krajewski S; Zhai D; Faustin B; Bruey JM; Bailly-Maitre B; Lichtenstein A; Kolluri SK; Satterthwait AC; Zhang XK; Reed JC
Blood; 2007 May; 109(9):3849-55. PubMed ID: 17227826
[TBL] [Abstract][Full Text] [Related]
18. Membrane-insertion fragments of Bcl-xL, Bax, and Bid.
García-Sáez AJ; Mingarro I; Pérez-Payá E; Salgado J
Biochemistry; 2004 Aug; 43(34):10930-43. PubMed ID: 15323553
[TBL] [Abstract][Full Text] [Related]
19. Bcl-x(S) can form homodimers and heterodimers and its apoptotic activity requires localization of Bcl-x(S) to the mitochondria and its BH3 and loop domains.
Lindenboim L; Borner C; Stein R
Cell Death Differ; 2001 Sep; 8(9):933-42. PubMed ID: 11526448
[TBL] [Abstract][Full Text] [Related]
20. BH3-only proteins Noxa, Bik, Bmf, and Bid activate Bax and Bak indirectly when studied in yeast model.
Gérecová G; Kopanicová J; Jaká P; Běhalová L; Juhásová B; Bhatia-Kiššová I; Forte M; Polčic P; Mentel M
FEMS Yeast Res; 2013 Dec; 13(8):747-54. PubMed ID: 23991648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
